Michael W. Jakowec

7.4k citations

85 papers · 5.8k indexed · 2 hit papers · h-index 35

Neurology top 0.2%
Cellular and Molecular Neuroscience top 0.5%
Molecular Biology top 10%
Psychiatry and Mental health top 1%
Neurology top 1%

Co-authors: Giselle M. Petzinger Beth E. Fisher Serge Przedborski Vernice Jackson‐Lewis John P. Walsh Robert E. Burke Jeff A. Beeler Sarah McEwen
Topics: Parkinson's Disease Mechanisms and Treatments (39 papers)Neurological disorders and treatments (27 papers)Neuroscience and Neuropharmacology Research (22 papers)
Cited by: Neurology Cellular and Molecular Neuroscience Physical Therapy, Sports Therapy and Rehabilitation
Journals: Journal of NeuroscienceSHILAP Revista de lepidopterologíaThe EMBO Journal
Partner nations: United States Canada Switzerland

In The Last Decade

Michael W. Jakowec

84 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease

2013 555 citations Giselle M. Petzinger, Beth E. Fisher et al. profile →
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1995 501 citations Vernice Jackson‐Lewis, Michael W. Jakowec et al. PubMed profile →

Peers

Countries citing papers authored by Michael W. Jakowec

Since Specialization

Citations

This map shows the geographic impact of Michael W. Jakowec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Jakowec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Jakowec more than expected).

Fields of papers citing papers by Michael W. Jakowec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Jakowec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Jakowec. The network helps show where Michael W. Jakowec may publish in the future.

Co-authorship network of co-authors of Michael W. Jakowec

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Jakowec. A scholar is included among the top collaborators of Michael W. Jakowec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Jakowec. Michael W. Jakowec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High baseline perivascular space volume in basal ganglia is associated with attention and executive function decline in Parkinson's disease 2024 ·Brain and Behavior ·(unknown),(unknown),(unknown),Dawn M. Schiehser,Andrew J. Petkus,Joseph O’Neill,Daniel P. Holschneider,Jeiran Choupan,John D. Van Horn,Ece Bayram,Irene Litvan,Michael W. Jakowec,Giselle M. Petzinger	6
2	A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease 2024 ·Molecular Psychiatry ·Su‐Jeong Kim,Brendan Miller,(unknown),Ricardo Ramírez,(unknown),(unknown),(unknown),(unknown),Thalida Em Arpawong,Eileen M. Crimmins,Penglong Wang,(unknown),Chunyu Liu,Daniel Levy,Kelvin Yen,Giselle M. Petzinger,Nicholas A. Graham,Michael W. Jakowec,Pinchas Cohen	9
3	Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function 2024 ·Cell & Bioscience ·(unknown),(unknown),(unknown),John K. Robinson,(unknown),(unknown),(unknown),(unknown),(unknown),Michael W. Jakowec,Daryl L. Davies,Jordan T. Yorgason	1
4	Data-driven sequence of cognitive decline in people with Parkinson’s disease 2024 ·Journal of Neurology Neurosurgery & Psychiatry ·Andrew J. Petkus,(unknown),Michael W. Jakowec,Ece Bayram,John D. Van Horn,Irene Litvan,Giselle M. Petzinger,Dawn M. Schiehser	0
5	Promoting Physical Activity in a Spanish-Speaking Latina Population of Low Socioeconomic Status With Chronic Neurological Disorders: Proof-of-Concept Study 2022 ·JMIR Formative Research ·(unknown),Jesús Díaz,Vy Bui,Janina Morrison,Beth E. Fisher,(unknown),(unknown),(unknown),David Wing,Lilyana Amezcua,Michael W. Jakowec,(unknown),Giselle M. Petzinger	1
6	Thalamic volume mediates associations between cardiorespiratory fitness (VO2max) and cognition in Parkinson's disease 2021 ·Parkinsonism & Related Disorders ·Andrew J. Petkus,Behnaz Jarrahi,Daniel P. Holschneider,(unknown),J. Vincent Filoteo,Dawn M. Schiehser,Beth E. Fisher,John D. Van Horn,Michael W. Jakowec,Sarah McEwen,Giselle M. Petzinger	6
7	The Effects of Cardiorespiratory and Motor Skill Fitness on Intrinsic Functional Connectivity of Neural Networks in Individuals with Parkinson’s Disease 2021 ·PubMed ·Behnaz Jarrahi,Sarah McEwen,Daniel P. Holschneider,Dawn M. Schiehser,Andrew J. Petkus,(unknown),(unknown),(unknown),Michael W. Jakowec,Giselle M. Petzinger	3
8	Knockdown of Astrocytic Monocarboxylate Transporter 4 in the Motor Cortex Leads to Loss of Dendritic Spines and a Deficit in Motor Learning 2021 ·Molecular Neurobiology ·(unknown),George N. Llewellyn,(unknown),(unknown),Paula M. Cannon,Giselle M. Petzinger,Michael W. Jakowec	13
9	Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington's disease 2017 ·Neurobiology of Disease ·Daniel P. Stefanko,(unknown),(unknown),Giselle M. Petzinger,Michael W. Jakowec	24
10	Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder 2016 ·Neuropharmacology ·(unknown),(unknown),(unknown),Stan G. Louie,Michael W. Jakowec,Liana Asatryan,Daryl L. Davies	21
11	The Effects of Exercise on Dopamine Neurotransmission in Parkinson’s Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry 2015 ·PubMed ·Giselle M. Petzinger,Daniel P. Holschneider,Beth E. Fisher,Sarah McEwen,Natalie Kintz,Matthew R. Halliday,(unknown),Joanne Walsh,Jeff A. Beeler,Michael W. Jakowec	115
12	P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders 2014 ·Frontiers in Neuroscience ·(unknown),Liana Asatryan,Michael W. Jakowec,James R. Trudell,Richard L. Bell,Daryl L. Davies	43
13	The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson’s Disease 2013 ·Frontiers in Neurology ·Jeff A. Beeler,Giselle M. Petzinger,Michael W. Jakowec	30
14	Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease 2013 ·Neurobiology of Disease ·(unknown),Giselle M. Petzinger,(unknown),Garnik Akopian,John P. Walsh,(unknown),Marta Vučković,Michael W. Jakowec	140
15	Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease 2010 ·Pharmacology Biochemistry and Behavior ·(unknown),Michael W. Jakowec,Giselle M. Petzinger,Ruth I. Wood	67
16	Association of MBP peptides with Hsp70 in normal appearing human white matter 2006 ·Journal of the Neurological Sciences ·Brett T. Lund,(unknown),(unknown),(unknown),Carolyn Bevan,Rodrigo Aguilera,Tim Gallaher,Michael W. Jakowec	21
17	Postnatal Expression of α-Synuclein Protein in the Rodent Substantia nigra and Striatum 2001 ·Developmental Neuroscience ·Michael W. Jakowec,David M. Donaldson,J. Barba,Giselle M. Petzinger	24
18	The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety 2001 ·Journal of Neurochemistry ·Serge Przedborski,Vernice Jackson‐Lewis,Ali Naini,Michael W. Jakowec,Giselle M. Petzinger,Renee M. Miller,Muhammad Akram	397
19	α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP 2000 ·Journal of Neurochemistry ·Miquel Vila,Slobodanka Vukosavić,Vernice Jackson‐Lewis,Michael Neystat,Michael W. Jakowec,Serge Przedborski	325
20	Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization 2000 ·The Journal of Comparative Neurology ·Maryka Quik,(unknown),Alison Gillespie,Michael W. Jakowec,G. Kenneth Lloyd,J. William Langston	148

About Michael W. Jakowec

Michael W. Jakowec is a scholar working on Neurology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 85 papers that have together received 5.8k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (27 papers) and Neuroscience and Neuropharmacology Research (22 papers). The work is most often cited by research in Neurology (3.1k citations), Cellular and Molecular Neuroscience (2.5k citations) and Physical Therapy, Sports Therapy and Rehabilitation (487 citations). Michael W. Jakowec has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Giselle M. Petzinger, Beth E. Fisher, Serge Przedborski, Vernice Jackson‐Lewis, John P. Walsh, Robert E. Burke, Jeff A. Beeler, Sarah McEwen, Marta Vučković and Garnik Akopian. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact